InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (9 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
9
T+90 hit rate
14%
T+90 mean return
-6.9%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by MCGUIRE TERRANCE, Director. Insider active across 6 companies, notably Cyclerion Therapeutics, Inc.. Aggregated, 24 filings have been recorded. Breakdown: 2 buys · 9 sells. Total volume traded: €11.6m. Activity tracked since 3 June 2021. The latest transaction was disclosed on 7 April 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations24 total
500,000 shares@ US$17.10100.0% of flowCommon StockSEC:0000950170-25-051671:0
83,744 shares@ US$0.52129.0% of flowCommon StockSEC:0000950170-24-141701:0
119,805 shares@ US$0.423410.5% of flowCommon StockSEC:0000950170-24-140613:0
97,410 shares@ US$0.489.6% of flowCommon StockSEC:0000950170-24-138597:0
125,000 shares@ US$0.58314.9% of flowCommon StockSEC:0000950170-24-136858:0
150,000 shares@ US$0.610418.7% of flowCommon StockSEC:0000950170-24-135509:0
1,073,062 sharesCommon StockSEC:0001415889-24-017975:0
58,178 shares0Class A Common StockSEC:0001415889-24-016917:0
112,381 shares@ US$1.660237.2% of flowCommon StockSEC:0000950170-24-067438:0
5,000 shares0Common StockSEC:0000950170-23-067740:0
500,000 shares@ US$6.00100.0% of flowCommon StockSEC:0000899243-23-018836:0
500,000 shares0Common StockSEC:0000899243-23-018381:0
8 shares@ US$3.3950.0% of flowCommon StockSEC:0000899243-23-018047:0
23,443 shares0Class A Common StockSEC:0001209191-23-038195:0
26,250 shares0Common StockSEC:0000950170-23-028274:0
500,000 shares0Common StockSEC:0000899243-22-036380:0
9,459 shares0Common StockSEC:0001209191-22-038544:0
9,945 shares0Class A Common StockSEC:0001209191-22-038119:0
500,000 shares0Common StockSEC:0000899243-21-049595
500,000 shares0Common StockSEC:0000899243-21-049595:0
2,852,425 sharesCommon StockSEC:0001209191-21-051297
2,852,425 sharesCommon StockSEC:0001209191-21-051297:0
92,831 shares@ US$3.124.94% mcap50.0% of flowCommon StockSEC:0000899243-21-022327:0
Ideal exit: 28 Feb 2022 (T+270)
92,831 shares@ US$3.1250.0% of flowCommon StockSEC:0000899243-21-022327
Ideal exit: 28 Feb 2022 (T+270)
24 of 24 declarations
About MCGUIRE TERRANCE
Terrance McGuire is a Board Member at Cyclerion Therapeutics, Inc., Adagio Therapeutics, Inc., and Alector, Inc. He plays a key role in the governance of these companies, participating in strategic decisions and overseeing operations. His experience in the biopharmaceutical sector is valuable for guiding growth initiatives.
